BURLINGTON, Mass., July 06, 2016 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that three new executives have joined the company in key marketing, medical affairs and market access roles. Mark Fraga, Scott Kelley, MD, and Dan Thornton take on vice president positions at Flexion as the company prepares to submit a new drug […]